Total Funding
54
41
Total FundingPost-IPO Equity raised
Growth Score
-12 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
22748
Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.
Colleen Delaney: Chief Scientific and Medical OfficerPast Role: Nohla Therapeutics, Founder and Chief Medical Officer- Dave Mehalick: CEO
About the Company
Coeptis Therapeutics is a clinical stage biotechnology company developing innovative cell therapy platforms for patients with cancer and other debilitating diseases. It focuses on the development and acquisition of pharmaceutical products. Its pipeline is evolving from the partnerships being created with multiple pharmaceutical companies. As the
relationships unfold, the product pipeline will be updated accordingly.
Women Founded
